Published guidance, NICE advice and quality standards | Guidance

Showing 491 to 500 of 2027

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments	TA862	1 February 2023	1 February 2023
Somatrogon for treating growth disturbance in children and young people aged 3 years and over	TA863	1 February 2023	1 February 2023
Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted	TA864	1 February 2023	1 February 2023
Delirium: prevention, diagnosis and management in hospital and long-term care	CG103	28 July 2010	18 January 2023
Maribavir for treating refractory cytomegalovirus infection after transplant	TA860	18 January 2023	18 January 2023
Trabeculectomy with a biodegradable collagen matrix implant for glaucoma	HTG656	17 January 2023	17 January 2023
Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (terminated appraisal)	TA859	16 January 2023	16 January 2023
Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education	NG213	9 March 2022	13 January 2023
MRI-based technologies for assessing non-alcoholic fatty liver disease	HTG655	12 January 2023	12 January 2023
Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma	TA857	11 January 2023	11 January 2023